United International Pharma (UIP)

What United International Pharma (UIP) does

United International Pharma (UIP) is a Vietnam-based pharmaceutical manufacturer and a 100% foreign-owned subsidiary of the United Laboratories (Unilab) Group, a Southeast Asian healthcare conglomerate operating across 10 countries with 12 manufacturing facilities and more than 350 brands. UIP was registered in 1995 with commercial operations in Vietnam dating to 1990, and is headquartered at its EU-GMP certified production facility in Binh Duong, with a transaction office in Ho Chi Minh City and a representative office in Hanoi. The company manufactures and distributes generic prescription drugs, OTC medications, and nutraceuticals across pain (Alaxan, Dolfenal), pediatric and adult vitamins (Ceelin, Ceelin+Z, Enervon), gastrointestinal health (Kremil-S, Kremil Gel, New Diatabs, Hydrite), clinical nutrition (FontActiv), women's health (Obimin), respiratory (Decolgen, Solmux), and diabetes (Sitagliptin Plus XR).

The technical platform is anchored by an EU-GMP certified manufacturing site (achieved January 2025) layered on prior WHO-GMP, ISO, GLP, and GSP credentials, supporting both branded production and export-grade contract manufacturing (CMO/CDMO/OEM). A proprietary extended-release formulation capability is evidenced by Sitagliptin Plus XR — the first generic extended-release Sitagliptin/Metformin combination on the Vietnamese market, demonstrating 99-101% bioequivalence versus the originator, a 58% reduction in gastrointestinal side effects, and an approximately 20% price advantage. The product is positioned as a technology-led market entry rather than a me-too generic.

UIP operates a B2B2C go-to-market. Revenue is generated through one-time product sales of OTC and prescription generics plus service-fee contract manufacturing. A dedicated field sales force executes medical detailing at retail pharmacies nationwide, supplemented by scientific symposiums and KOL engagement with medical associations (e.g., the Vietnam Diabetes and Endocrinology Association, Tam Anh General Hospital). Distribution runs through Vietnamese retail pharmacy chains, with a Zalo-based loyalty program (GBP) providing direct-to-consumer digital engagement. Customer segments include general pharmacy consumers, chronic disease patients (notably diabetes and GI), women in the prenatal/postnatal window, and pediatric caregivers.

Name

United International Pharma (UIP)

Legal name

Công ty TNHH United International Pharma

Website

https://unitedpharma.com.vn

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

11–50 employees

Short description

United International Pharma (UIP) is a Vietnam-based generic pharmaceutical manufacturer and Unilab Group subsidiary producing OTC, prescription, and nutraceutical products at its EU-GMP certified Binh Duong facility, serving Vietnamese consumers via retail pharmacy chains and offering export-grade contract manufacturing services.

Ownership category

akta.pro rank

Product category

Generic Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)

akta.pro secondary industries

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), OTC & Consumer Health Distributors (HLAIAJAC)

Keywords

• Generic pharmaceutical manufacturing
• Over-the-counter medications
• Contract pharmaceutical manufacturing
• Women's health supplements
• Pediatric vitamin syrups

Headquarters

HQ city

Ho Chi Minh City

HQ country

Vietnam

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: UIP generates revenue through the manufacture and sale of generic pharmaceutical products (OTC and prescription drugs) across therapeutic categories including pain relief, vitamins and minerals, digestive health, respiratory, nutritional supplements, and women's health. Products are sold through retail pharmacies and healthcare providers in Vietnam and export markets.
2. Contract Manufacturing Services (CMO/CDMO): UIP offers contract manufacturing services including New Product Development (CDMO/ODM) for pharmaceutical and nutraceutical products, and toll manufacturing (CMO/OEM) of finished dosage forms under EU-GMP standards. The company also provides regulatory dossier preparation for EU and Asia-Pacific export markets.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

United International Pharma (UIP) manufactures and sells a portfolio of generic pharmaceutical products, OTC medications, and nutraceutical supplements in Vietnam across pain relief, respiratory, gastrointestinal, vitamins, clinical nutrition, women's health, and diabetes categories. UIP operates an EU-GMP certified manufacturing facility in Binh Duong and additionally offers contract manufacturing services (CMO/OEM and CDMO/ODM) plus regulatory dossier preparation for export markets. Products are distributed through retail pharmacy networks, pharmacy chains, and healthcare providers under brands including Alaxan, Decolgen, Kremil-S, Enervon, Ceelin, Obimin, and Sitagliptin Plus XR.

Product overview

United International Pharma (UIP) is a pharmaceutical company manufacturing and distributing generic drugs, OTC medications, and nutraceuticals in Vietnam. The product portfolio includes therapeutic categories spanning Pain management (Alaxan®, Dolfenal®), Vitamins & Wellness (Enervon®, Ceelin®, Ceelin®+Z), Gastro-Intestinal health (Kremil-S®, Kremil® Gel, New Diatabs®, Hydrite®), Clinical Nutrition (FontActiv® Complete, FontActiv® diaBest), Women's Health (OBIMIN® Calcium, OBIMIN® Plus), Respiratory (Decolgen® FORTE, Solmux® TL), and Diabetes (Sitagliptin Plus XR). UIP operates EU-GMP certified manufacturing facilities in Binh Duong and offers contract manufacturing (CDMO/ODM/CMO/OEM), export, and exclusive distribution partnership services.

Differentiator

Problem solved

Functional benefit

Brands

• OBIMIN: Women's health product line including OBIMIN Multivitamins, OBIMIN Plus (with DHA & EPA), and OBIMIN Calcium for prenatal and bone health support.
• CEELIN
• CEELIN+Z
• Decolgen Forte
• Alaxan
• Kremil-S
• Kremil Gel
• Dolfenal
• Enervon
• FontActiv
• Hydrite
• New Diatabs
• Solmux TL
• Sitagliptin Plus XR

Products and services

• Alaxan® Pain relief medication for the Vietnamese market, distributed through retail pharmacies and used by general consumers.
• Ceelin® Vitamin C syrup for children, available in Vietnam since 2002; used for prevention and treatment of Vitamin C deficiency in pediatric patients.
• Ceelin®+Z Advanced pediatric syrup combining Vitamin C and Zinc, designed for prevention and treatment of Vitamin C and/or Zinc deficiency in children and for immune support.
• Decolgen® FORTE Cold and flu medication sold through retail pharmacies in Vietnam to general consumers.
• Dolfenal® Anti-inflammatory pain relief medication sold through retail pharmacies in Vietnam.
• Enervon® Vitamin and nutritional supplement for general energy and wellness, sold through retail pharmacies in Vietnam.
• FontActiv® Complete Nutritional supplement for general health, sold through pharmacies in Vietnam as part of UIP's clinical nutrition range.
• FontActiv® diaBest Nutritional supplement specifically formulated for diabetic patients, sold through pharmacies in Vietnam as part of UIP's clinical nutrition range.
• Hydrite® Granules Oral rehydration granules for treating dehydration, sold through retail pharmacies in Vietnam.
• Hydrite® Tablets Oral rehydration tablets for treating dehydration, sold through retail pharmacies in Vietnam.
• Kremil-S® Chewable tablet antacid for relieving indigestion, heartburn, and bloating, containing Aluminium hydroxide 178 mg, Magnesium hydroxide 233 mg, and Simethicone 30 mg per tablet.
• Kremil® Gel Gel-formulation antacid for relieving indigestion, heartburn, and bloating, containing Aluminium hydroxide 356 mg, Magnesium hydroxide 466 mg, and Simethicone 20 mg per 20 mL sachet.
• New Diatabs® Anti-diarrheal medication containing Attapulgite 600 mg for treating symptoms of acute and chronic diarrhea.
• OBIMIN® Calcium Calcium supplement with Vitamin D3 and FOS supporting bone health, calcium absorption, and osteoporosis prevention. Contains Calcium 600 mg, Magnesium 50 mg, and Vitamin D3 200 IU per tablet. Targeted at women for prenatal/postnatal and bone health.
• OBIMIN® Plus Prenatal/postnatal multivitamin soft capsule containing Omega 3 (DHA 105 mg, EPA 20 mg), Vitamin C, Calcium, Iron, and other essential nutrients for women planning pregnancy, pregnant, or breastfeeding, supporting fetal brain and vision development.
• Solmux® TL Respiratory medication sold through retail pharmacies in Vietnam for respiratory conditions.
• Sitagliptin Plus XR First generic combination product of Sitagliptin 100 mg and Metformin HCl 1000 mg in extended-release form for Type 2 diabetes treatment. Targets physicians, hospitals, and patients requiring affordable, bioequivalent chronic disease therapy.
• Contract Manufacturing Services (CMO / OEM and CDMO / ODM) Contract manufacturing (toll / CMO/OEM) and new product development (CDMO/ODM) services for pharmaceutical and nutraceutical products, performed under EU-GMP certified standards, with regulatory dossier preparation for EU and Asia-Pacific market registration. Sold to other pharmaceutical companies seeking manufacturing capacity or product development support.

Quantifiable outcome

• GI side effects reduced by up to 58% with extended-release Sitagliptin Plus XR formulation
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Long Châu PharmacycoreChannel Partner/ Reseller/ Distributor · 1 June 2026UIP partnered with Long Châu pharmacy chain to deliver two hands-on training sessions for pharmacists in June 2026. The training focused on consultation skills and selling techniques at the point of sale, helping pharmacists identify customer needs and recommend appropriate solutions through interactive activities and case-based discussions.
• Vietnam Women's UnioncoreStrategic or Co-development Partner · 1 March 2026Obimin Calcium, in collaboration with the Vietnam Women's Union and local authorities, conducted a series of five community health sessions in March and April. The program focused on bone and joint health education and nutrition, combining health screenings (spinal checks, AI-based bone age assessment) with personalized nutrition advice and self-care guidance.
• Local Health AuthoritiesminorStrategic or Co-development Partner · 1 March 2026Obimin Calcium community health program conducted in partnership with local government health authorities for five community health sessions focusing on bone health and nutrition education.
• CEELIN+ZcoreStrategic or Co-development Partner · 1 January 2026UIP collaborated with CEELIN+Z brand to host the 2026 Children's Day celebration at the HCMC office, welcoming employees' children for creative activities including a 'Plant a Tree & Paint a Pot' workshop. The partnership supports family engagement and workplace culture initiatives.
• United Laboratories (Unilab) GroupcoreOthersUIP is a member of United Laboratories (Unilab) Group, a Southeast Asian healthcare group with operations in 10 Asia-Pacific countries, producing over 350 pharmaceutical brands through 12 manufacturing facilities. Unilab provides global R&D expertise, manufacturing standards, and product development support to UIP.

Scale indicators5 records

Recent moves13 records

Expansion highlights6 records

Direct peers

• Imexpharm Pharmaceutical JSC: Imexpharm is a Vietnamese pharmaceutical manufacturer producing generic and OTC products with GMP-certified manufacturing, distributing through retail pharmacy networks. Comparable to UIP as a domestic generic manufacturer with similar product mix, regulatory positioning, and channel strategy in Vietnam.
• Pymepharco JSC: Pymepharco is a Vietnamese generic pharmaceutical manufacturer producing antibiotics, cardiovascular, and OTC products for domestic and export markets, now part of Stada. Comparable to UIP as a GMP-certified Vietnamese generic manufacturer with export ambitions and overlapping therapeutic category coverage.
• DHG Pharmaceutical Joint Stock Company: DHG Pharma is Vietnam's largest domestic pharmaceutical manufacturer, producing generic drugs, OTC medications, and nutraceuticals across pain, respiratory, vitamins, and digestive categories. Directly comparable to UIP as both operate EU/WHO-GMP-certified Vietnamese manufacturing, distribute through retail pharmacy networks, and target overlapping therapeutic categories with similar generic-plus-OTC commercial models.
• Traphaco Joint Stock Company: Traphaco is a leading Vietnamese pharmaceutical manufacturer with a heritage brand portfolio spanning OTC, traditional medicine, and consumer health products distributed primarily through retail pharmacies. Comparable to UIP in product mix (OTC-led, multi-therapeutic), distribution strategy (pharmacy chains and independent outlets), and Vietnam-domestic commercial orientation.
• Hau Giang Pharmaceutical JSC: Hau Giang Pharmaceutical (now part of DHG Pharma/STADA) is a Vietnamese generic pharma manufacturer with established brands across OTC and prescription categories. Comparable to UIP in product categories (OTC pain, respiratory, vitamins), pharmacy distribution model, and Vietnamese manufacturing footprint.
• Mekophar Chemical & Pharmaceutical JSC: Mekophar is a Vietnamese pharmaceutical manufacturer producing generic drugs, OTC products, and APIs with GMP-certified facilities in Ho Chi Minh City. Directly comparable to UIP as a Vietnam-based generic pharma manufacturer with similar product categories, GMP manufacturing standards, and pharmacy distribution focus.

Broad incumbents

• Abbott Vietnam: Abbott operates in Vietnam with nutritional products, diagnostics, and pharmaceuticals, including consumer health brands like Ensure and Similac. Comparable to UIP in clinical nutrition and OTC consumer health categories (overlapping with FontActiv nutritional supplements) distributed through pharmacy and retail channels.
• Bayer Vietnam: Bayer operates in Vietnam with pharmaceutical, consumer health, and crop science divisions, with OTC brands like Aspirin and Berocca. Comparable to UIP in OTC consumer health categories (pain relief, vitamins) distributed through Vietnamese retail pharmacies, but at significantly larger scale and global brand recognition.
• Sanofi Vietnam: Sanofi operates in Vietnam with a broad pharmaceutical portfolio including prescription drugs, vaccines, and consumer health/OTC products distributed through pharmacy channels. Comparable to UIP as a multinational with OTC presence in Vietnam overlapping in categories like pain relief and digestive health, but with substantially broader resources and originator-brand positioning.

Regional players

• Kalbe Farma: Kalbe Farma is Indonesia's largest pharmaceutical manufacturer with a broad generic, OTC, and consumer health portfolio distributed across Southeast Asia. Comparable to UIP as a Southeast Asian pharma manufacturer with similar product mix (OTC, vitamins, prescription generics), pharmacy distribution model, and emerging market growth profile.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@unitedinternationalpharma
• Facebookfacebook.com/unitedinternationalpharma
• LinkedInlinkedin.com/company/unitedinternationalpharma

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about United International Pharma (UIP)